220 related articles for article (PubMed ID: 32901107)
1. High MHC-II expression in Epstein-Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation.
Ghasemi F; Tessier TM; Gameiro SF; Maciver AH; Cecchini MJ; Mymryk JS
Sci Rep; 2020 Sep; 10(1):14786. PubMed ID: 32901107
[TBL] [Abstract][Full Text] [Related]
2. High Levels of Class I Major Histocompatibility Complex mRNA Are Present in Epstein-Barr Virus-Associated Gastric Adenocarcinomas.
Ghasemi F; Gameiro SF; Tessier TM; Maciver AH; Mymryk JS
Cells; 2020 Feb; 9(2):. PubMed ID: 32098275
[TBL] [Abstract][Full Text] [Related]
3. High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells.
Gameiro SF; Ghasemi F; Barrett JW; Nichols AC; Mymryk JS
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31394808
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
6. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
[TBL] [Abstract][Full Text] [Related]
7. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
8. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.
Luo B; Wang Y; Wang XF; Liang H; Yan LP; Huang BH; Zhao P
World J Gastroenterol; 2005 Feb; 11(5):629-33. PubMed ID: 15655811
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
[TBL] [Abstract][Full Text] [Related]
10. The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules.
Keating S; Prince S; Jones M; Rowe M
J Virol; 2002 Aug; 76(16):8179-88. PubMed ID: 12134023
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes.
Kim SY; Park C; Kim HJ; Park J; Hwang J; Kim JI; Choi MG; Kim S; Kim KM; Kang MS
Gastroenterology; 2015 Jan; 148(1):137-147.e9. PubMed ID: 25254613
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.
Zuo J; Thomas WA; Haigh TA; Fitzsimmons L; Long HM; Hislop AD; Taylor GS; Rowe M
PLoS Pathog; 2011 Dec; 7(12):e1002455. PubMed ID: 22216005
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppression.
Jiang XN; Yu BH; Yan WH; Lee J; Zhou XY; Li XQ
Oncoimmunology; 2020; 9(1):1683346. PubMed ID: 32002294
[No Abstract] [Full Text] [Related]
15. Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein-Barr virus-associated gastric cancer: implication for viral-induced immune evasion.
Dutta N; Gupta A; Mazumder DN; Banerjee S
Cancer; 2006 Apr; 106(8):1685-93. PubMed ID: 16541432
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion.
Salnikov M; Prusinkiewicz MA; Lin S; Ghasemi F; Cecchini MJ; Mymryk JS
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680216
[TBL] [Abstract][Full Text] [Related]
17. Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases.
van Beek J; zur Hausen A; Snel SN; Berkhof J; Kranenbarg EK; van de Velde CJ; van den Brule AJ; Middeldorp JM; Meijer CJ; Bloemena E
Am J Surg Pathol; 2006 Jan; 30(1):59-65. PubMed ID: 16330943
[TBL] [Abstract][Full Text] [Related]
18. Frequency of Epstein--Barr virus infection as detected by messenger RNA for EBNA 1 in histologically proven gastric adenocarcinoma in patients presenting to a tertiary care center in South India.
Rymbai ML; Ramalingam VV; Samarasan I; Chandran BS; Mathew G; Jerobin J; Abraham AM; Sachithanandham J; Kannangai R
Indian J Med Microbiol; 2015; 33(3):369-73. PubMed ID: 26068337
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma.
Wang Y; Luo B; Yan LP; Huang BH; Zhao P
World J Gastroenterol; 2005 Jun; 11(21):3234-9. PubMed ID: 15929173
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations.
Böger C; Krüger S; Behrens HM; Bock S; Haag J; Kalthoff H; Röcken C
Ann Oncol; 2017 May; 28(5):1005-1014. PubMed ID: 28453696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
